TFRC and breast cancer: However, our results support the therapeutic success of HEve in a relevant panel of BCs and the quick HFn uptake observed by confocal microscopy in all BC cell lines (Figure 2) suggests that the advantage due to delivery could be similarly effective in cells with different TfR1 expression levels.